ZA892258B - Use of isoxazolinones as cerebro-active drugs - Google Patents

Use of isoxazolinones as cerebro-active drugs

Info

Publication number
ZA892258B
ZA892258B ZA892258A ZA892258A ZA892258B ZA 892258 B ZA892258 B ZA 892258B ZA 892258 A ZA892258 A ZA 892258A ZA 892258 A ZA892258 A ZA 892258A ZA 892258 B ZA892258 B ZA 892258B
Authority
ZA
South Africa
Prior art keywords
alkyl
isoxazolinones
cerebro
hydrogen
active drugs
Prior art date
Application number
ZA892258A
Other languages
English (en)
Inventor
Nobuyoshi Iwata
Iwata Nobuyoshi
Kazuo Kobayashi
Kobayashi Kazuo
Yoshiko Kubo
Kubo Yoshiko
Masao Kozuko
Kozuko Masao
Mitsuo Nagano
Nagano Mitsuo
Original Assignee
Sankyo Co Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Limited filed Critical Sankyo Co Limited
Publication of ZA892258B publication Critical patent/ZA892258B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA892258A 1988-03-24 1989-03-28 Use of isoxazolinones as cerebro-active drugs ZA892258B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7042788 1988-03-24

Publications (1)

Publication Number Publication Date
ZA892258B true ZA892258B (en) 1990-12-28

Family

ID=13431170

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA892258A ZA892258B (en) 1988-03-24 1989-03-28 Use of isoxazolinones as cerebro-active drugs

Country Status (8)

Country Link
EP (1) EP0334674B1 (xx)
KR (1) KR890014111A (xx)
AT (1) ATE106243T1 (xx)
CA (1) CA1329128C (xx)
DE (1) DE68915595T2 (xx)
ES (1) ES2057110T3 (xx)
IE (1) IE69021B1 (xx)
ZA (1) ZA892258B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116839A (en) * 1989-06-26 1992-05-26 Sankyo Company, Limited Use of isoxazolin-3-one derivatives as antidepressants
US5217970A (en) * 1989-06-26 1993-06-08 Sankyo Company, Limited Use of isoxazolin-3-one derivatives as antidepressants
US5262413A (en) * 1989-06-26 1993-11-16 Sankyo Company, Limited Use of isoxazolin-3-one derivatives as antidepressants
CZ284343B6 (cs) * 1990-05-11 1998-10-14 Sankyo Company Limited Piperidyloxy-a chinuklidinyloxyisoxazolové deriváty, způsob jejich výroby a použití

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459862A (en) * 1967-12-12 1969-08-05 Geigy Chem Corp Isoxazole derivatives and processes for making them
IT1190736B (it) * 1982-03-15 1988-02-24 Delalande Sa Uso terapeutico di derivati noti 5-amminonetil-ossazolidin-2-one
JPS6183170A (ja) * 1984-09-28 1986-04-26 Nippon Chemiphar Co Ltd 新規な１，３−オキサゾリジン−２−オン誘導体およびその製造法
DE3438839A1 (de) * 1984-10-19 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische praeparate
JPH0713017B2 (ja) * 1986-06-18 1995-02-15 日本ケミファ株式会社 脳細胞保護作用を有する医薬組成物
ZA879631B (en) * 1986-12-26 1989-08-30 Sankyo Co Centrally-acting muscle relaxants

Also Published As

Publication number Publication date
KR890014111A (ko) 1989-10-21
EP0334674A2 (en) 1989-09-27
EP0334674A3 (en) 1990-09-12
ATE106243T1 (de) 1994-06-15
IE69021B1 (en) 1996-07-24
IE890977L (en) 1989-09-24
DE68915595T2 (de) 1994-09-15
ES2057110T3 (es) 1994-10-16
EP0334674B1 (en) 1994-06-01
CA1329128C (en) 1994-05-03
DE68915595D1 (de) 1994-07-07

Similar Documents

Publication Publication Date Title
GR3002113T3 (en) Quinazoline derivatives
DE69019111D1 (de) Ascorbinsäure-Tocopheryl-Phosphatdiester zur Hemmung der Maillard-Reaktion.
MX9701292A (es) Compuestos espiro-azabiciclicos utiles en la terapia.
GR861925B (en) Bactericide preparations for veterinary medicine
ZA89389B (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
PT82032A (en) Process for the preparation of anticonvulsant amino acid derivatives and of pharmaceutical compositions containing the same
HK1006284A1 (en) Thiazolidine derivatives having anti-hypertensive activity and their therapeutic use
ES2109216T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica con actividad relajante muscular de accion central.
EP0334674A3 (en) Use of isoxazolinones as cerebro-active drugs
EP0263506A3 (en) Anticonvulsant composition containing amino acid derivative and use of said amino acid derivative
GR3006108T3 (xx)
ATE160567T1 (de) Psoralen-derivate, deren herstellung und verwendung als arzneimittel
SE8305362D0 (sv) Novel substituted phenylazacycloalkanes, processes for preparation and pharmaceutical preparations for such compounds